AVAvadel Pharmaceuticals plc AVDL · NASDAQ
$21.64 +0.00% (+$0.00)
- Market cap
- $2.12B
- Enterprise value
- $2.08B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 8.5x
- P/FCF
- 60.0x
- EV/EBITDA
- 205.5x
- ROIC
- 0.3%
- Gross margin
- 94.5%
- Net margin
- -0.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -4.2x
- Beta
- 1.31
- Free float
- 93.3%
About the company
Avadel Pharmaceuticals plc (AVDL) is an Irish pharmaceutical company focused on the development and commercialization of medicines for the treatment of neurological and cardiovascular diseases. With a product portfolio including drugs such as FT218 and Noctiva, Avadel Pharmaceuticals aims to provide innovative therapeutic options for patients suffering from various conditions. The company emphasizes research and development of new drug formulations and treatment approaches to meet the needs of patients and the medical community. Avadel Pharmaceuticals plc (AVDL) shares could be suitable for investors looking for investments in the pharmaceutical industry with a focus on innovative therapies and drug development for neurological and cardiovascular diseases.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Gregory J. Divis Jr.
Employees
188
Headquarters
Dublin
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 14 USD is left as free cash.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: Operating profit does not even cover the interest on its debt.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number